Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35947641)

  • 21. [The role of alternative lengthening of telomeres mechanisms in carcinogenesis and prospects for using an anti-telomerase drugs in malignant tumors treatment].
    Grach AA
    Tsitologiia; 2011; 53(10):759-71. PubMed ID: 22232932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression.
    Subhawong AP; Heaphy CM; Argani P; Konishi Y; Kouprina N; Nassar H; Vang R; Meeker AK
    Mod Pathol; 2009 Nov; 22(11):1423-31. PubMed ID: 19734843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.
    Bower K; Napier CE; Cole SL; Dagg RA; Lau LM; Duncan EL; Moy EL; Reddel RR
    PLoS One; 2012; 7(11):e50062. PubMed ID: 23185534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
    De Vitis M; Berardinelli F; Sgura A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
    Gocha ARS; Harris J; Groden J
    Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
    Lovejoy CA; Li W; Reisenweber S; Thongthip S; Bruno J; de Lange T; De S; Petrini JH; Sung PA; Jasin M; Rosenbluh J; Zwang Y; Weir BA; Hatton C; Ivanova E; Macconaill L; Hanna M; Hahn WC; Lue NF; Reddel RR; Jiao Y; Kinzler K; Vogelstein B; Papadopoulos N; Meeker AK;
    PLoS Genet; 2012; 8(7):e1002772. PubMed ID: 22829774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
    Grobelny JV; Kulp-McEliece M; Broccoli D
    Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma.
    Lee YK; Park NH; Lee H
    Int J Gynecol Cancer; 2012 Mar; 22(3):434-41. PubMed ID: 22266933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome.
    Hartlieb SA; Sieverling L; Nadler-Holly M; Ziehm M; Toprak UH; Herrmann C; Ishaque N; Okonechnikov K; Gartlgruber M; Park YG; Wecht EM; Savelyeva L; Henrich KO; Rosswog C; Fischer M; Hero B; Jones DTW; Pfaff E; Witt O; Pfister SM; Volckmann R; Koster J; Kiesel K; Rippe K; Taschner-Mandl S; Ambros P; Brors B; Selbach M; Feuerbach L; Westermann F
    Nat Commun; 2021 Feb; 12(1):1269. PubMed ID: 33627664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WRN loss induces switching of telomerase-independent mechanisms of telomere elongation.
    Gocha AR; Acharya S; Groden J
    PLoS One; 2014; 9(4):e93991. PubMed ID: 24709898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative Lengthening of Telomeres in the Budding Yeast
    Cohn M; Andersson AK; Mateo RQ; Möller MC
    G3 (Bethesda); 2019 Oct; 9(10):3345-3358. PubMed ID: 31427453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
    Min J; Wright WE; Shay JW
    Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ALT--alternative lengthening of telomere].
    Wu XM; Tang WR; Luo Y
    Yi Chuan; 2009 Dec; 31(12):1185-91. PubMed ID: 20042385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.
    Feng X; Luo Z; Jiang S; Li F; Han X; Hu Y; Wang D; Zhao Y; Ma W; Liu D; Huang J; Songyang Z
    J Cell Sci; 2013 Sep; 126(Pt 17):3982-9. PubMed ID: 23813958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors.
    Alzoubi H; Minasi S; Gianno F; Antonelli M; Belardinilli F; Giangaspero F; Jaffrain-Rea ML; Buttarelli FR
    Endocr Pathol; 2022 Dec; 33(4):494-505. PubMed ID: 34993885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
    Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
    Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unified alternative telomere-lengthening pathway in yeast survivor cells.
    Kockler ZW; Comeron JM; Malkova A
    Mol Cell; 2021 Apr; 81(8):1816-1829.e5. PubMed ID: 33639094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.
    Wang N; Xu D; Sofiadis A; Höög A; Vukojević V; Bäckdahl M; Zedenius J; Larsson C
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1571-9. PubMed ID: 24758186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Telomere Recombination in Normal Mammalian Cells].
    Zhdanova NS; Rubtsov NB
    Genetika; 2016 Jan; 52(1):14-23. PubMed ID: 27183789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.